SITC's guide to managing immunotherapy toxicity

A practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs.

Part One contains chapter-based overviews of immune checkpoint inhibitors in the clinic.

Part Two is structured by common and uncommon toxicities that affect major organ sites throughout the body.